Literature DB >> 20101513

Successful management of a patient with Marfan syndrome complicated with acute aortic dissection using landiolol during Cesarean section.

Noboru Saeki1, Shima Taguchi, Masashi Kawamoto.   

Abstract

Aortic dissection is a lethal complication in pregnant women with Marfan syndrome. To decrease arterial wall stress, beta-blockers have been used as standard treatment, although uterine contractions caused by beta-2-adrenergic receptor antagonism may result. Herein, we report a patient with Marfan syndrome who was given landiolol, a selective beta-1-adrenergic receptor antagonist with a short half-life, for management during a Cesarean section procedure following development of acute aortic dissection. A 30-year-old pregnant woman with Marfan syndrome in the 38th week of gestation was referred to our department for an emergency Cesarean section because of development of acute aortic dissection. Blood pressure (BP) decreased from 157/70 to 128/64 mmHg after giving nicardipine and nitroglycerin. However, heartrate (HR) increased from 112 to 145 bpm, which was reduced to 105 bpm with landiolol, while BP was maintained. A Cesarean section was performed without complications under combined spinal-epidural anesthesia. Hemodynamic state, uterine contraction, and the extent of aortic dissection remained stable. The postoperative course was uneventful, and the patient and her baby were discharged safely. Landiolol was useful for reduction of HR without affecting BP or uterine contractions during a Cesarean section procedure in our patient with aortic dissection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20101513     DOI: 10.1007/s00540-009-0859-8

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  18 in total

1.  [Anesthetic management of parturients with Marfan syndrome].

Authors:  F Handa; Y Ohnishi; Y Takauchi; M Kuro
Journal:  Masui       Date:  2001-04

2.  Expert consensus document on management of cardiovascular diseases during pregnancy.

Authors: 
Journal:  Eur Heart J       Date:  2003-04       Impact factor: 29.983

3.  The effect of beta-blocker therapy on clinical outcome in patients with Marfan's syndrome: a meta-analysis.

Authors:  Deborah R Gersony; Mary Ann McClaughlin; Zhezhen Jin; Welton M Gersony
Journal:  Int J Cardiol       Date:  2006-07-10       Impact factor: 4.164

4.  [Reproductive and developmental toxicity studies of landiolol hydrochloride (ONO-1101) (4). Perinatal and postnatal study in rats].

Authors:  T Nishimura; N Chihara; R Shirakawa; S Sugai; T Sakamoto; Y Nakagawa; Y Aze; K Shimouchi; Y Ozeki; T Fujita
Journal:  J Toxicol Sci       Date:  1997-12       Impact factor: 2.196

5.  Dural ectasia is a common feature of the Marfan syndrome.

Authors:  R E Pyeritz; E K Fishman; B A Bernhardt; S S Siegelman
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

Review 6.  The Marfan syndrome: diagnosis and management.

Authors:  R E Pyeritz; V A McKusick
Journal:  N Engl J Med       Date:  1979-04-05       Impact factor: 91.245

7.  Outcome of pregnancy in women with Marfan's syndrome.

Authors:  K J Lipscomb; J C Smith; B Clarke; P Donnai; R Harris
Journal:  Br J Obstet Gynaecol       Date:  1997-02

8.  Serial study of factors influencing changes in cardiac output during human pregnancy.

Authors:  S C Robson; S Hunter; R J Boys; W Dunlop
Journal:  Am J Physiol       Date:  1989-04

9.  A comparison between the effect of oxytocin only and oxytocin plus propranolol on the labor (a double blind randomized trial).

Authors:  Maryam Kashanian; Mohsen Fekrat; Zahra Zarrin; Narges S Ansari
Journal:  J Obstet Gynaecol Res       Date:  2008-06       Impact factor: 1.730

10.  A prospective longitudinal evaluation of pregnancy in the Marfan syndrome.

Authors:  J P Rossiter; J T Repke; A J Morales; E A Murphy; R E Pyeritz
Journal:  Am J Obstet Gynecol       Date:  1995-11       Impact factor: 8.661

View more
  1 in total

1.  Pregnancy and Marfan syndrome.

Authors:  Sorel Goland; Uri Elkayam
Journal:  Ann Cardiothorac Surg       Date:  2017-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.